Table 1.
Dermatitis Herpetiformis | Coeliac Disease | |
---|---|---|
Gender | Slightly more males | Females predominate |
Age at onset | Mainly adults | Children and adults |
IgA-TG3 deposits in the skin | 100% | 0% |
Small bowel villous atrophy | 75% | 100% * |
IgA-TG2 deposits in the small bowel mucosa [36,37] | 80% | up to 100% ** |
Prevalence in Finland and United Kingdom [18,19,38] | 75 and 30 per 100,000 | 660 and 240 per 100,000 |
Incidence | Decreasing | Increasing |
Response to a gluten-free diet [7,8,20] | Slow; months, in the beginning most patients need dapsone to control the rash | Rapid; days or weeks until gastro-intestinal symptoms end whereas small bowel villous atrophy may persist for many years |
Long-term prognosis on a gluten-free diet [39,40,41] | Excellent | All-cause and lymphoma mortality may be increased |
TG3 = epidermal transglutaminase, TG2 = tissue transglutaminase; * Potential coeliac disease with normal small bowel mucosa architecture, inflammation and positive TG2 serology also exist; ** Data still sparse.